JANX JANUX THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Suspension of Prospectus Supplement Janux Therapeutics, Inc. has suspended the prospectus supplement related to its common stock and will not make any sales unless a new supplement is filed.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC